Search Orphan Drug Designations and Approvals
-
Generic Name: | rapamycin |
---|---|
Date Designated: | 02/24/2016 |
Orphan Designation: | Treatment of facial angiofibromas (FA) associated with tuberous sclerosis complex (TSC). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AFT Pharmaceuticals Ltd. 129 Hurstmere Road Level 1, Nielsen Building Takapuna, Auckland New Zealand The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-